These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

436 related articles for article (PubMed ID: 21499742)

  • 21. Association of variants in MYH7, MYBPC3 and TNNT2 with sudden cardiac death-related risk factors in Brazilian patients with hypertrophic cardiomyopathy.
    Mori AA; Castro LR; Bortolin RH; Bastos GM; Oliveira VF; Ferreira GM; Hirata TDC; Fajardo CM; Sampaio MF; Moreira DAR; Pachón-Mateos JC; Correia EB; Sousa AGMR; Brión M; Carracedo A; Hirata RDC; Hirata MH
    Forensic Sci Int Genet; 2021 May; 52():102478. PubMed ID: 33588347
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Risk of syncope in family members who are genotype-negative for a family-associated long-QT syndrome mutation.
    Barsheshet A; Moss AJ; McNitt S; Polonsky S; Lopes CM; Zareba W; Robinson JL; Ackerman MJ; Benhorin J; Kaufman ES; Towbin JA; Vincent GM; Qi M; Goldenberg I
    Circ Cardiovasc Genet; 2011 Oct; 4(5):491-9. PubMed ID: 21831960
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification of an ethnic-specific variant (V207M) of the KCNQ1 cardiac potassium channel gene in sudden unexplained death and implications from a knock-in mouse model.
    Nishio H; Kuwahara M; Tsubone H; Koda Y; Sato T; Fukunishi S; Tamura A; Suzuki K
    Int J Legal Med; 2009 May; 123(3):253-7. PubMed ID: 19198868
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Yield of molecular and clinical testing for arrhythmia syndromes: report of 15 years' experience.
    Hofman N; Tan HL; Alders M; Kolder I; de Haij S; Mannens MM; Lombardi MP; Dit Deprez RH; van Langen I; Wilde AA
    Circulation; 2013 Oct; 128(14):1513-21. PubMed ID: 23963746
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prognostic predictive value of gene mutations in Japanese patients with hypertrophic cardiomyopathy.
    Chida A; Inai K; Sato H; Shimada E; Nishizawa T; Shimada M; Furutani M; Furutani Y; Kawamura Y; Sugimoto M; Ishihara J; Fujiwara M; Soga T; Kawana M; Fuji S; Tateno S; Kuraishi K; Kogaki S; Nishimura M; Ayusawa M; Ichida F; Yamazawa H; Matsuoka R; Nonoyama S; Nakanishi T
    Heart Vessels; 2017 Jun; 32(6):700-707. PubMed ID: 27885498
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical and Genetic Diagnosis of Nonischemic Sudden Cardiac Death.
    Jiménez-Jáimez J; Alcalde Martínez V; Jiménez Fernández M; Bermúdez Jiménez F; Rodríguez Vázquez Del Rey MDM; Perin F; Oyonarte Ramírez JM; López Fernández S; de la Torre I; García Orta R; González Molina M; Cabrerizo EM; Álvarez Abril B; Álvarez M; Macías Ruiz R; Correa C; Tercedor L
    Rev Esp Cardiol (Engl Ed); 2017 Oct; 70(10):808-816. PubMed ID: 28566242
    [TBL] [Abstract][Full Text] [Related]  

  • 27. KCNQ1 mutations in patients with a family history of lethal cardiac arrhythmias and sudden death.
    Chen S; Zhang L; Bryant RM; Vincent GM; Flippin M; Lee JC; Brown E; Zimmerman F; Rozich R; Szafranski P; Oberti C; Sterba R; Marangi D; Tchou PJ; Chung MK; Wang Q
    Clin Genet; 2003 Apr; 63(4):273-82. PubMed ID: 12702160
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Functional assessment of compound mutations in the KCNQ1 and KCNH2 genes associated with long QT syndrome.
    Grunnet M; Behr ER; Calloe K; Hofman-Bang J; Till J; Christiansen M; McKenna WJ; Olesen SP; Schmitt N
    Heart Rhythm; 2005 Nov; 2(11):1238-49. PubMed ID: 16253915
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical characteristics of patients with congenital long QT syndrome and bigenic mutations.
    Jimmy JJ; Chen CY; Yeh HM; Chiu WY; Yu CC; Liu YB; Tsai CT; Lo LW; Yeh SF; Lai LP
    Chin Med J (Engl); 2014; 127(8):1482-6. PubMed ID: 24762593
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Molecular Genetic Basis of Hypertrophic Cardiomyopathy.
    Marian AJ
    Circ Res; 2021 May; 128(10):1533-1553. PubMed ID: 33983830
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Disease penetrance and risk stratification for sudden cardiac death in asymptomatic hypertrophic cardiomyopathy mutation carriers.
    Michels M; Soliman OI; Phefferkorn J; Hoedemaekers YM; Kofflard MJ; Dooijes D; Majoor-Krakauer D; Ten Cate FJ
    Eur Heart J; 2009 Nov; 30(21):2593-8. PubMed ID: 19666645
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A comparison of genetic findings in sudden cardiac death victims and cardiac patients: the importance of phenotypic classification.
    Hertz CL; Ferrero-Miliani L; Frank-Hansen R; Morling N; Bundgaard H
    Europace; 2015 Mar; 17(3):350-7. PubMed ID: 25345827
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Allelic dropout in long QT syndrome genetic testing: a possible mechanism underlying false-negative results.
    Tester DJ; Cronk LB; Carr JL; Schulz V; Salisbury BA; Judson RS; Ackerman MJ
    Heart Rhythm; 2006 Jul; 3(7):815-21. PubMed ID: 16818214
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Novel mutations of potassium channel KCNQ1 S145L and KCNH2 Y475C genes in Chinese pedigrees of long QT syndrome].
    Liu WL; Hu DY; Li P; Li CL; Qin XG; Li YT; Li L; Li ZM; Dong W; Qi Y; Wang Q
    Zhonghua Nei Ke Za Zhi; 2006 Jun; 45(6):463-6. PubMed ID: 16831322
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cardiac channel molecular autopsy: insights from 173 consecutive cases of autopsy-negative sudden unexplained death referred for postmortem genetic testing.
    Tester DJ; Medeiros-Domingo A; Will ML; Haglund CM; Ackerman MJ
    Mayo Clin Proc; 2012 Jun; 87(6):524-39. PubMed ID: 22677073
    [TBL] [Abstract][Full Text] [Related]  

  • 36. KCNQ1 and KCNH2 mutations associated with long QT syndrome in a Chinese population.
    Liu W; Yang J; Hu D; Kang C; Li C; Zhang S; Li P; Chen Z; Qin X; Ying K; Li Y; Li Y; Li Z; Cheng X; Li L; Qi Y; Chen S; Wang Q
    Hum Mutat; 2002 Dec; 20(6):475-6. PubMed ID: 12442276
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cascade screening in families with inherited cardiac diseases driven by cardiologists: feasibility and nationwide outcome in long QT syndrome.
    Theilade J; Kanters J; Henriksen FL; Gilså-Hansen M; Svendsen JH; Eschen O; Toft E; Reimers JI; Tybjærg-Hansen A; Christiansen M; Jensen HK; Bundgaard H
    Cardiology; 2013; 126(2):131-7. PubMed ID: 23969902
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Posthumous diagnosis of long QT syndrome from neonatal screening cards.
    Gladding PA; Evans CA; Crawford J; Chung SK; Vaughan A; Webster D; Neas K; Love DR; Rees MI; Shelling AN; Skinner JR
    Heart Rhythm; 2010 Apr; 7(4):481-6. PubMed ID: 20167303
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Value of Genetic Testing for the Prediction of Long-Term Outcome in Patients With Hypertrophic Cardiomyopathy.
    van Velzen HG; Vriesendorp PA; Oldenburg RA; van Slegtenhorst MA; van der Velden J; Schinkel AFL; Michels M
    Am J Cardiol; 2016 Sep; 118(6):881-887. PubMed ID: 27476098
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical and ECG variables to predict the outcome of genetic testing in hypertrophic cardiomyopathy.
    Robyns T; Breckpot J; Nuyens D; Vandenberk B; Corveleyn A; Kuiperi C; Van Aelst L; Van Cleemput J; Willems R
    Eur J Med Genet; 2020 Mar; 63(3):103754. PubMed ID: 31513939
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.